Propanc Biopharma Inc. (PPCB)
NASDAQ: PPCBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 9:32 AM ET
PPCB stock chart
Technical analysisKey statistics
All statistics- Market cap
- $4.72M
- EPS (TTM)
- -$17.62
- Dividend yield
- None
- 52-week range
- 0.46 – 48.75
- Day range
- 0.4804 – 0.4974
- Volume / Avg
- 15.84K / 1.79M
- Beta
- —
- Shares outstanding
- 9.83M
52-week range
PPCB stock today
On Oct 8, PPCB is trading at $0.4804, shedding $0.0183 (3.67%), versus the S&P 500's 0.25% decline. Shares are 99.0% below their 52-week high of $48.75 and 4.4% above the 52-week low of $0.46, near the bottom of the past year's range. Propanc Biopharma has posted a net loss over the last twelve months (EPS of -$17.62), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Propanc Biopharma
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Propanc Biopharma peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| XTLBXTL Biopharmaceuticals Ltd. ADR | 1.97 | -0.50% | $4.84M | vs PPCB |
| RDHLRedhill Biopharma Ltd. ADR | 0.5279 | +11.37% | $4.69M | vs PPCB |
| NCNANuCana plc ADR | 1.12 | -1.75% | $4.66M | vs PPCB |
| LNAILunai Bioworks Inc. | 1.14 | +4.59% | $5.17M | vs PPCB |
| XBIOXenetic Biosciences Inc. | 2.21 | +2.55% | $5.18M | vs PPCB |
| PULMPulmatrix Inc. | 1.49 | +4.20% | $5.44M | vs PPCB |
| DRMADermata Therapeutics Inc. | 1.12 | 0.00% | $5.55M | vs PPCB |
| BGMSBio Green Med Solution Inc. | 0.85 | 0.00% | $5.63M | vs PPCB |
Indexes, lists and sector
Propanc Biopharma stock FAQ
What is Propanc Biopharma's stock price today?
PPCB last traded at $0.4804 as of Oct 8, 9:32 AM EDT, down 3.67% on the day. Prices are delayed at least 15 minutes.
What is the PPCB 52-week high?
The 52-week high for PPCB is $48.75 and the 52-week low is $0.46. The stock is currently 99.0% below its high.